Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Observational Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice

NCT02655159 is registered in ClinicalTrials.gov with Celgene Corporation as lead sponsor.

NCT NCT02655159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02655159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Observational Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice
Lead sponsor
Celgene Corporation
Phase
Observational
Overall status
Terminated
Start date
January 31, 2016
Completion date
August 31, 2016
Enrollment
46 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms